In contrast to these earlier findings, where KLF15 has been identified for its pathological role in HFD-induced insulin resistance and hepatic steatosis, under fasting conditions, KLF15 was identified to inhibit hepatic lipogenesis by suppressing the Srebf1c transcription [86]. The gene discussed is KLF15; the disease is fatty liver disease.